HIV Drug Raltegravir Shows Promise Against Alzheimer's Brain Damage in Lab Study
Researchers found that the HIV medication raltegravir protected brain cells from Alzheimer's-related damage in laboratory tests.
2017 articles in this topic
Researchers found that the HIV medication raltegravir protected brain cells from Alzheimer's-related damage in laboratory tests.
Study of 1,890 geriatric patients finds metformin, ACE inhibitors, aspirin and beta-blockers significantly reduce mortality risk.
New research reveals how low-grade inflammation creates a cycle of liver damage in older adults, pointing to promising therapeutic targets.
Higher fibrinogen and immune activation scores in middle age strongly predicted who would develop frailty decades later.
New research reveals circular RNAs in mitochondria that decrease with aging and may regulate cellular energy production and longevity.
New genetic study reveals opposing effects of inflammatory markers on mortality, with IL6 receptor showing protective benefits.
New research reveals how cells with extra chromosomes enter senescence, linking development, tissue repair, and cancer prevention.
Scientists developed a single-cell aging clock showing COVID-19 and HIV speed up immune aging in specific T cell types.
New research reveals that declining cellular energy production drives aging and death, but this process evolved to help species survive.
New neural networks accurately estimate biological age within 6 years using blood markers or gut bacteria composition.
New primate study reveals vitamin C prevents harmful iron buildup that accelerates aging by blocking a key enzyme pathway.
Six-hour eating window produces 4.3% weight loss in PCOS patients, matching traditional calorie restriction without counting calories.